Pfizer responds to FDA, EMA and Canada after reinspections of plant that makes injected painkillers

Pfizer says it has made significant strides in upgrading the sterile injectables plant where it manufactures many of its generic painkillers but acknowledges more must be done after reinspections by the FDA and other regulators.